Castle Biosciences (CSTL) Shares Outstanding (2018 - 2026)

Castle Biosciences has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $30.5 million in Q2 2026.

• Quarterly Shares Outstanding (Entity) rose 5.27% year-over-year to $30.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $30.5 million (up 5.27% YoY) and the FY2025 annual result came in at $29.7 million, up 4.22% from the prior year.
• Shares Outstanding (Entity) grew to $30.5 million in Q2 2026 per CSTL's latest filing, from $30.3 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $30.5 million in Q2 2026 and troughed at $25.5 million in Q1 2022.
• A 5-year average of $27.9 million and a median of $27.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) climbed 1.72% in 2022, then gained 5.27% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $26.6 million in 2022, then gained by 3.23% to $27.4 million in 2023, then climbed by 3.91% to $28.5 million in 2024, then climbed by 4.22% to $29.7 million in 2025, then rose by 2.77% to $30.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $30.5 million, $30.3 million, and $29.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.